1Chandrasekar P.Diagnostic challenges and recent advances in the early management of invasive fungal infections[J].Eur J Haematol,2010,84(4):281-290.
2Ascioglu S,Rex JH,de Pauw B,et al.Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants:an international consensus[J].Clin Infect Dis,2002,34(1):7-14.
3Stevens DA.Diagnosis of fungal infections:current status[J].J Antimicrob Chemother,2002,49(Suppl.1):11-19.
4Kelaher A.Two non-invasive diagnostic tools for invasive aspergilosis:(1-3)-beta-D-glucan and the galactomannan assay[J].Clin Lab Sci,2006,19(4):222-224.
5Pazos C,Ponton J,del Palacio A.Contribution of (1-3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients:a comparison with serial screening for circulating galactomannan[J].J Clin Microbiol,2005,43(1):299-305.
